Effects of (pre-)analytical variables on activated protein C resistance determined via a thrombin generation-based assay.
Curvers J, Christella M, Thomassen LG, de Ronde H, Bertina RM, Rosendaal FR, Tans G, Rosing J
Purpose
Conclusion
Studies (1)
Purpose
The purpose of this study was to determine the effects of patient genotype and condition, trisodium citrate concentration, delayed centrifugation, centrifugation protocol, frozen storage temperature, freeze-thaw cycling, and assay parameters on nAPC-sr. Blood was obtained without pressure, and the first 2 mL were discarded. A single centrifugation at 2,000 x g for 15 min was compared to centrifugation at 3000 x g for 15 min followed by 20,000 x g for 30 min. All plasma was frozen at either -20 or -80 degrees C for 3 months before analysis.
Summary of Findings
The highest n-APC-sr was observed in the woman who was heterozygous for factor V Leiden and also pregnant, but the other 2 individuals heterozygous for factor V Leiden had nAPC-sr levels that were comparable to those in the 5 normal individuals not taking oral contraceptives and lower than those in the 3 normal individuals taking oral contraceptives. The largest factor affecting nAPC-sr was the citrate concentration with an average increase of 0.74 observed when the citrate concentration increased from 3.2 to 3.8%, and this increase was smaller in specimens with high nAPC-sr. An average increase in nAPC-sr levels of 0.149 was observed when centrifugation was delayed by 24 h compared to specimens that were centrifuged immediately. Only small effects were found after a 4 h delay in centrifugation (0.016), or between centrifugation protocols (0.089), frozen storage temperatures (0.023) or 1 versus 2 freeze-thaw cycles (0.035), but significance was not determined. The assay was also affected by APC, thrombin, calcium, and phospholipid concentrations.
Biospecimens
FluidBloodFluidPlasmaPreservation Types
FrozenDiagnoses
NormalOther diagnosesPregnantPlatforms
ProteinHematology/ auto analyzerPre-analytical Factors
Classification Pre-Analytical Factor Value(s) Preaquisition Diagnosis/ patient condition Factor V Leiden heterozygousNormalPregnantPreaquisition Other drugs No oral contraceptivesOral contraceptivesPreaquisition Patient genotype Factor V Leiden heterozygousNormalBiospecimen Acquisition Anticoagulant Multiple concentrations evaluatedSodium citrateBiospecimen Aliquots and Components Centrifugation Centrifugation delays investigatedDifferent number of centrifugation steps comparedMultiple speeds comparedStorage Freeze/thaw cycling 1 cycle2 cyclesStorage Storage temperature -20 degrees C-80 degrees CStorage Time at room temperature 0 h24 h4 hHematology/ auto analyzer Specific Reaction solution 0-10 nM APC0-2.9 ng/mL Tissue factor0-32 mM CaCl20-32 uM phospholipid